CSF1R and glioma: Here, we performed a multimodal, dual-tracer imaging study in a syngeneic mouse model of glioma applying 18F-FET and 18F-DPA-714 PET using a CSF-1R inhibitor to investigate the interplay between glioma progression and related immune cell dynamics.